MoneyWorks4Me

Medicamen Biotech informs about outcome of board meeting

06 Mar 2018 Evaluate

Medicamen Biotech has informed that the Board of Directors at their meeting held today has allotted the 324000 Equity Shares, at a price of Rs 618 per share including premium of Rs 608 each ranking pari passu with the existing equity share holders of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..